Targeting VEGF in cancer therapy

Curr Probl Cancer. 2006 Jan-Feb;30(1):7-32. doi: 10.1016/j.currproblcancer.2005.11.001.

Authors

Erin A Donovan¹, Shivaani Kummar

Affiliation

¹ Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

PMID: 16443047
DOI: 10.1016/j.currproblcancer.2005.11.001

No abstract available

Publication types

Review

MeSH terms

Antibodies / therapeutic use
Breast Neoplasms / therapy
Carcinoma, Renal Cell / therapy
Colorectal Neoplasms / therapy
Drug Delivery Systems
Humans
Kidney Neoplasms / therapy
Lung Neoplasms / therapy
Neoplasms / drug therapy
Neoplasms / therapy*
Oligonucleotides, Antisense / therapeutic use
Protein-Tyrosine Kinases / antagonists & inhibitors
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Vascular Endothelial Growth Factor A / physiology

Substances

Antibodies
Oligonucleotides, Antisense
Vascular Endothelial Growth Factor A
Protein-Tyrosine Kinases